Nachrichten zur Acorda Therapeutics Aktie

Acorda (ACOR) Soars on Sale of Manufacturing Unit for Inbrija

Acorda (ACOR) inks an agreement to sell its Inbrija manufacturing operations in Chelsea for $80 million to Catalent. The company…

ACOR Rises On Restructuring, ALXN Pauses COVID-19 Trial, SYBX On Watch

Todays Daily Dose brings you news about Acordas restructuring; Alexions decision to pause its COVID-19 trial; and analysts rating on…

Acorda Therapeutics, NuCana leads healthcare gainers; Zomedica, Forward Pharma among major losers

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Acorda Therapeutics to sell Inbrija manufacturing operations for $80M, reduces headcount by 16%, shares up 65%

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

ACORDA THERAPEUTICS INC: 8-K Report

8-K...…

The Daily Biotech Pulse: Bausch Health Issues Positive Pre-Announcement, Acorda Streamlines Operations

Heres a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week…

XFRA : CDG: Aussetzung/Suspension

DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT: THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT: INSTRUMENT NAME …

XFRA : ISIN Change

Einstellung Aufnahme ISIN Name Einstellung mit Ablauf: ISIN Name Ab dem: Anmerkungen US68235B1098 180 Degree Capital Corp. 04.01.2021 US68235B2088 180 Degree Capital Corp. 05.01.2021 Tausch 3:1 CA98880A2056 Angold Resources Ltd. ...…

XFRA : Deletion of Instruments from Boerse Frankfurt- 04.01.21

The following instruments on Boerse Frankfurt do have their last trading day on 04.01.2021 Die folgenden Instrumente in Boerse Frankfurt haben…

Bionano Genomics, Ocugen leads healthcare gainers; Calithera Biosciences, Acorda Therapeutics among major losers

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

XFRA : INSTRUMENT_SUSPENSION EQUBF_01

Instrument ID [8134] (CDG - US00484M1062) suspended...…

Acorda Therapeutics completes 1-for-6 reverse stock split

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

ACORDA THERAPEUTICS INC: 8-K Report

8-K...…

What Makes Acorda (ACOR) a New Buy Stock

Acorda (ACOR) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the companys earnings prospects. This…

ACORDA THERAPEUTICS INC: 8-K Report

8-K...…

ACORDA THERAPEUTICS INC: 8-K Report

8-K...…

Acorda Therapeutics, Inc. 2020 Q3 - Results - Earnings Call Presentation

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Acorda Therapeutics, Inc. (ACOR) CEO Ron Cohen on Q3 2020 Results - Earnings Call Transcript

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Acorda Therapeutics (ACOR) Reports Q3 Loss, Tops Revenue Estimates

Acorda (ACOR) delivered earnings and revenue surprises of 23.33% and 80.64%, respectively, for the quarter ended September 2020. Do the…

ACORDA THERAPEUTICS INC: 8-K Report

8-K...…

Acorda Therapeutics: Q3 Earnings Insights

Shares of Acorda Therapeutics (NASDAQ:ACOR) increased 8.33% after the company reported Q3 results. Quarterly Results Earnings per share rose 50.00% over the…

Acorda Therapeutics EPS beats by $0.07, beats on revenue

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Acorda Therapeutics EPS beats by $0.10, beats on revenue

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Acorda Therapeutics (ACOR) May Report Negative Earnings: Know the Trend Ahead of Q3 Release

Acorda (ACOR) doesnt possess the right combination of the two key ingredients for a likely earnings beat in its upcoming…

Thinking about buying stock in Aptinyx, Acorda Therapeutics, T-Mobile, Best Buy, or Advanced Micro Devices?

NEW YORK , Oct. 20, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for…

Acorda Therapeutic to receive $15M milestone payment from Biogen

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

ACORDA THERAPEUTICS INC: 8-K Report

8-K...…

ACORDA THERAPEUTICS INC: 8-K Report

8-K...…

Are Options Traders Betting on a Big Move in Acorda Therapeutics (ACOR) Stock?

Investors need to pay close attention to Acorda Therapeutics (ACOR) stock based on the movements in the options market lately....…

ACORDA THERAPEUTICS INC: 8-K Report

8-K...…

ACORDA THERAPEUTICS INC: 8-K Report

8-K...…

Acorda Therapeutics, Inc. (ACOR) CEO Ron Cohen on Q2 2020 Results - Earnings Call Transcript

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Acorda Therapeutics (ACOR) Reports Q2 Loss, Tops Revenue Estimates

Acorda (ACOR) delivered earnings and revenue surprises of 23.91% and 27.56%, respectively, for the quarter ended June 2020. Do the…

ACORDA THERAPEUTICS INC: 8-K Report

8-K...…

ACORDA THERAPEUTICS INC: 8-K Report

8-K...…

ACORDA THERAPEUTICS INC: 8-K Report

8-K...…

ACORDA THERAPEUTICS INC: 8-K Report

8-K...…

ACORDA THERAPEUTICS INC: 8-K Report

8-K...…

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Acorda Therapeutics, Inc. - ACOR

New York, New York--(Newsfile Corp. - June 16, 2020) - Levi & Korsinsky has commenced an investigation of Acorda Therapeutics,…